Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
14.19
+0.07 (0.50%)
Nov 13, 2024, 4:00 PM EST - Market closed
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ELAN stock have an average target of 17, with a low estimate of 14 and a high estimate of 20. The average target predicts an increase of 19.80% from the current stock price of 14.19.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ELAN stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +40.94% | Nov 8, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +33.90% | Oct 28, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +55.04% | Sep 23, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +40.94% | Sep 19, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $17 → $15 | Buy → Hold | Downgrades | $17 → $15 | +5.71% | Sep 19, 2024 |
Financial Forecast
Revenue This Year
4.52B
from 4.42B
Increased by 2.22%
Revenue Next Year
4.64B
from 4.52B
Increased by 2.77%
EPS This Year
0.94
from -2.50
EPS Next Year
0.96
from 0.94
Increased by 1.96%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.7B | 4.8B | 5.1B | ||
| Avg | 4.5B | 4.6B | 4.8B | ||
| Low | 4.3B | 4.4B | 4.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.5% | 7.3% | 10.8% | ||
| Avg | 2.2% | 2.8% | 4.5% | ||
| Low | -3.5% | -2.1% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.00 | 1.10 | 1.26 | ||
| Avg | 0.94 | 0.96 | 1.10 | ||
| Low | 0.88 | 0.80 | 0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 17.3% | 31.5% | ||
| Avg | - | 2.0% | 14.9% | ||
| Low | - | -14.6% | 2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.